ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Addex Therapeutics Ltd

Addex Therapeutics Ltd (0QNV)

3.02
0.00
( 0.00% )
업데이트: 09:00:00

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
3.02
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
3.02 52주 범위 3.02
market_cap
전일 종가
3.02
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
699
발행 주식
184,354,000
배당수익률
-
주가수익률
-52.71
주당순이익(EPS)
-0.06
매출
1.61M
순이익
-10.56M

Addex Therapeutics Ltd 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Geneva, Che
설립됨
-
Addex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker 0QNV. The last closing price for Addex Therapeutics was CHF3.02. Over the last year, Addex Therapeutics shares have traded in a share price range of CHF 3.02 to CHF 3.02.

Addex Therapeutics currently has 184,354,000 shares in issue. The market capitalisation of Addex Therapeutics is CHF556.75 million. Addex Therapeutics has a price to earnings ratio (PE ratio) of -52.71.

0QNV 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1003.023.023.0200DE
4003.023.023.022373.02DE
12003.023.023.026993.02DE
26003.023.023.023113.02DE
52003.023.023.029363.02DE
156003.023.023.027943.02DE
260003.023.023.027653.02DE

0QNV - Frequently Asked Questions (FAQ)

What is the current Addex Therapeutics share price?
The current share price of Addex Therapeutics is CHF 3.02
How many Addex Therapeutics shares are in issue?
Addex Therapeutics has 184,354,000 shares in issue
What is the market cap of Addex Therapeutics?
The market capitalisation of Addex Therapeutics is CHF 556.75M
What is the 1 year trading range for Addex Therapeutics share price?
Addex Therapeutics has traded in the range of CHF 3.02 to CHF 3.02 during the past year
What is the PE ratio of Addex Therapeutics?
The price to earnings ratio of Addex Therapeutics is -52.71
What is the cash to sales ratio of Addex Therapeutics?
The cash to sales ratio of Addex Therapeutics is 347.13
What is the reporting currency for Addex Therapeutics?
Addex Therapeutics reports financial results in CHF
What is the latest annual turnover for Addex Therapeutics?
The latest annual turnover of Addex Therapeutics is CHF 1.61M
What is the latest annual profit for Addex Therapeutics?
The latest annual profit of Addex Therapeutics is CHF -10.56M
What is the registered address of Addex Therapeutics?
The registered address for Addex Therapeutics is 12 CHEMIN DES AULX, GENEVA, 1228
What is the Addex Therapeutics website address?
The website address for Addex Therapeutics is www.addextherapeutics.com
Which industry sector does Addex Therapeutics operate in?
Addex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
WSGWestminster Group Plc
1.40p
(27.27%)
2.57M
WHRWarehouse Reit Plc
98.80p
(16.51%)
5.43M
MET1Metals One Plc
0.575p
(15.00%)
1.8M
ZENZenith Energy Ltd.
7.75p
(14.81%)
1.97M
CORCorpus Resources Plc
0.016p
(14.29%)
186.59M
SAVESavannah Energy Plc
9.30p
(-64.57%)
160.62M
VELAVela Technologies Plc
0.003p
(-40.00%)
852.85M
TIGTeam Internet Group Plc
59.20p
(-39.96%)
3.25M
ALBAAlba Mineral Resources
0.014p
(-24.32%)
80.81M
SYMESupply@me Capital Plc
0.003p
(-23.08%)
19.14M
VELAVela Technologies Plc
0.003p
(-40.00%)
852.85M
TRPTower Resources Plc
0.023p
(-2.13%)
201.66M
CORCorpus Resources Plc
0.016p
(14.29%)
186.59M
SAVESavannah Energy Plc
9.30p
(-64.57%)
160.62M
TOMTomco Energy Plc
0.0425p
(-19.05%)
149.88M
gedi8 gedi8 5 분 전
We will see my friend. His first month in office has really hurt the market. I hope you are right
NXPL
WooptdooU WooptdooU 6 분 전
Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.
LWLG
louieforpar louieforpar 6 분 전
Less than four one way or another. 


glenn1919 glenn1919 7 분 전
INLF....................................................................................p/m
INLF
uranium-pinto-beans uranium-pinto-beans 7 분 전
OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve
OKTA
WooptdooU WooptdooU 8 분 전
These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.
LWLG
uranium-pinto-beans uranium-pinto-beans 9 분 전
mmmm


https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account
uranium-pinto-beans uranium-pinto-beans 10 분 전
OKTA
Okta price target raised to $100 from $94 at Canaccord
Canaccord raised the firm's price target on Okta to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported resoundingly positive Q4 results ahead of both the firm's and consensus expectations with
OKTA
uranium-pinto-beans uranium-pinto-beans 11 분 전
MCHP
Microchip cyclical bottom may be forming, says JPMorgan
Jefedejefes Jefedejefes 12 분 전
listening to your favorite song... over, and over, and over https://www.youtube.com/watch?v=BfnjX88Va4Y
EDXC
docj docj 16 분 전
"One example: the current CEO of Cytodyn was CMO under Nader Pourhassan the Frauder, and was fine with all his actions."

That is a false statement. It is a matter of public record how Dr JL felt about Nader. Stop trying to make it look like he was complicit with Nader's actions. It lo
CYDY
meixatech meixatech 16 분 전
"Oral bioavailability" is one of the most important properties in drug design and development. A high oral bioavailability reduces the amount of an administered drug necessary to achieve a desired pharmacological effect and therefore could reduce the risk of side-effects and toxicity.
RSPI
trader53 trader53 17 분 전
Nixon's Restaurants have not gone belly up


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
______________________________________________________________________


Nixon Restaurant Group Inc
is operated in Colorado ,
gp22 gp22 17 분 전
$ESLA @ $1.05....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s 2 weeks ago and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-complete-response-160000432.h
ESLA IOVA SMMT
WooptdooU WooptdooU 19 분 전
Grifter siraj...eom
LWLG
StockWorkOrange StockWorkOrange 22 분 전
Aw. Someone is upset their Picture Pump didn't work this time. Oh well. I'm sure you'll come up with something new to get these bAABBoons to hand over some more money.......
AABB
hedge_fun hedge_fun 23 분 전
They’ll need to be careful with their…….,

updates, won’t they?

They say the device pinpoints treasure, right?

If they’re diving and coming up empty, then Houston, don’t we have a problem?

Of course they could always be doing something wit
SFRX
StockWorkOrange StockWorkOrange 23 분 전
We all see how well you and the pump crew are doing on X with your 20 likes. Keep up the good work Alidare. It really seems to be working......#ticktock
AABB
glenn1919 glenn1919 23 분 전
AEON.......SPPL........RETO........PTIX.........................................................................p/m
PTIX RETO SPPL
WeTheMarket WeTheMarket 23 분 전
UK, any comments on the Earnings Report/10K? Are you still out and plan to stay out or do you see signs of hope for the future?
PLUG
glenn1919 glenn1919 24 분 전
AEON..........................................https://stockcharts.com/h-sc/ui?s=AEON&p=W&b=5&g=0&id=p86431144783
AEON
Jackxkr Jackxkr 25 분 전
At this moment what happens after approval is not as worrying as getting approval. As each day passes chances of approval goes down from here.
NWBO
edbi46 edbi46 28 분 전
On REDDIT 3 months ago:
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an el
BMI LMT QUBT

최근 히스토리

Delayed Upgrade Clock